Monitoring Requirements The Endocrine Society guideline specifies that prescribers should assess weight, heart rate, glycemic markers, and GI tolerability at each follow-up, with visits at least every 3 months during the first year 22
Some of these things include: whether or not you are having symptoms from the fibroids if you might want to become pregnant in the future the size of the fibroids the location of the fibroids your age and how close to menopause you might be If you have fibroids but do not have any symptoms, you may not need treatment
Estradiol Patch Product Images NDC 68382-325 View Photos of Packaging, Regulatory Labels, and Product Appearance Product Visual Gallery This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 68382-325)
Sanjeev Sockalingam, scientific director of Obesity Canada and chief medical officer at the Centre for Addiction and Mental Health in Toronto
Shels hormone therapy plan depends on the patients medical history, goals, and needs
57 (5), 481491 (1990) C.H
